Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome
PaperCitations, authors & open-access status
Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2023 year and closed oa status.
10
Citations
2023
Year
closed
OA Status